Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jun Ho Ji

Showing results (11-20 of 66) with videos related to

Pageof 7
Sort By:
Biomed Research International|July 1, 2015
Workplace Exposure to Titanium Dioxide Nanopowder Released from a Bag Filter SystemJun Ho Ji, Jong Bum Kim, Gwangjae Lee, et al.
Safety and Health at Work|September 7, 2012
In vivo Genotoxicity of Silver Nanoparticles after 90-day Silver Nanoparticle Inhalation ExposureJin Sik Kim, Jae Hyuck Sung, Jun Ho Ji, et al.
Toxicology and Industrial Health|September 28, 2010
Acute inhalation toxicity of silver nanoparticlesJae Hyuck Sung, Jun Ho Ji, Kyung Seuk Song, et al.
Journal of Cancer|March 14, 2022
Safety and anti-tumor effects of vismodegib in patients with refractory advanced gastric cancer: A single-arm, phase-II trialRyul Kim, Jun Ho Ji, Jung Hoon Kim, et al.
The Korean Journal of Internal Medicine|February 23, 2016
Treatment outcomes and clinical relevance of the Follicular Lymphoma International Prognostic Index in Korean follicular lymphoma patients treated with chemotherapyChi Hoon Maeng, Sung Woo Ahn, Seong-Yoon Ryu, et al.
Cancers|April 23, 2022
Modified FOLFIRINOX as a Second-Line Treatment for Patients with Gemcitabine-Failed Advanced Biliary Tract Cancer: A Prospective Multicenter Phase II StudyYong-Pyo Lee, Sung Yong Oh, Kwang Min Kim, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 19, 2013
Metabolic response evaluated by 18F-FDG PET/CT as a potential screening tool in identifying a subgroup of patients with advanced non-small cell lung cancer for immediate maintenance therapy after first-line chemotherapySeung Hwan Moon, Su-Hee Cho, Lee Chun Park, et al.
Cancer Chemotherapy and Pharmacology|December 9, 2016
The role of adjuvant therapy after R0 resection for patients with intrahepatic and perihilar cholangiocarcinomasYoung Saing Kim, Sung Yong Oh, Se-Il Go, et al.
Medicine|February 1, 2019
Sedation for terminally ill cancer patients: A multicenter retrospective cohort study in South KoreaYoung Saing Kim, Haa-Na Song, Jin Seok Ahn, et al.
Journal of Clinical Medicine|May 13, 2023
Efficacy and Safety of Chemotherapy in Elderly Patients with Unresectable Pancreatic CancerByung Soo Kwan, Ok Jae Lee, Hyun Jin Kim, et al.
Pageof 7

Showing results (11-20 of 66) with videos related to

Sort By:
Pageof 7
Biomed Research International|July 1, 2015
Workplace Exposure to Titanium Dioxide Nanopowder Released from a Bag Filter SystemJun Ho Ji, Jong Bum Kim, Gwangjae Lee, et al.
Safety and Health at Work|September 7, 2012
In vivo Genotoxicity of Silver Nanoparticles after 90-day Silver Nanoparticle Inhalation ExposureJin Sik Kim, Jae Hyuck Sung, Jun Ho Ji, et al.
Toxicology and Industrial Health|September 28, 2010
Acute inhalation toxicity of silver nanoparticlesJae Hyuck Sung, Jun Ho Ji, Kyung Seuk Song, et al.
Journal of Cancer|March 14, 2022
Safety and anti-tumor effects of vismodegib in patients with refractory advanced gastric cancer: A single-arm, phase-II trialRyul Kim, Jun Ho Ji, Jung Hoon Kim, et al.
The Korean Journal of Internal Medicine|February 23, 2016
Treatment outcomes and clinical relevance of the Follicular Lymphoma International Prognostic Index in Korean follicular lymphoma patients treated with chemotherapyChi Hoon Maeng, Sung Woo Ahn, Seong-Yoon Ryu, et al.
Cancers|April 23, 2022
Modified FOLFIRINOX as a Second-Line Treatment for Patients with Gemcitabine-Failed Advanced Biliary Tract Cancer: A Prospective Multicenter Phase II StudyYong-Pyo Lee, Sung Yong Oh, Kwang Min Kim, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 19, 2013
Metabolic response evaluated by 18F-FDG PET/CT as a potential screening tool in identifying a subgroup of patients with advanced non-small cell lung cancer for immediate maintenance therapy after first-line chemotherapySeung Hwan Moon, Su-Hee Cho, Lee Chun Park, et al.
Cancer Chemotherapy and Pharmacology|December 9, 2016
The role of adjuvant therapy after R0 resection for patients with intrahepatic and perihilar cholangiocarcinomasYoung Saing Kim, Sung Yong Oh, Se-Il Go, et al.
Medicine|February 1, 2019
Sedation for terminally ill cancer patients: A multicenter retrospective cohort study in South KoreaYoung Saing Kim, Haa-Na Song, Jin Seok Ahn, et al.
Journal of Clinical Medicine|May 13, 2023
Efficacy and Safety of Chemotherapy in Elderly Patients with Unresectable Pancreatic CancerByung Soo Kwan, Ok Jae Lee, Hyun Jin Kim, et al.
Pageof 7